Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site, Prospective, Longitudinal, Cohort Study Measuring Cerebrospinal Fluid-Mutant Huntingtin Protein in Patients With Huntington's Disease

NCT03664804 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03664804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03664804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site, Prospective, Longitudinal, Cohort Study Measuring Cerebrospinal Fluid-Mutant Huntingtin Protein in Patients With Huntington's Disease
Lead sponsor
Hoffmann-La Roche
Phase
Phase 1
Overall status
Completed
Start date
December 5, 2018
Completion date
May 7, 2022
Enrollment
95 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease